(Updated - May 10, 2024 4:58 AM EDT)

Barclays analyst Leon Wang downgraded Rapt Therapeutics (NASDAQ: RAPT) from Overweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE